Frédéric Dugay

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Florian Cabillic, Audrey Gros, Frédéric Dugay et al. · Journal of Thoracic Oncology · 2014 · 150 citations · Full text

Medicine, Genetics, Oncology +14

Differential diagnosis of atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: utility of p16 in combination with MDM2 and CDK4 immunohistochemistry

Solène‐Florence Kammerer‐Jacquet, Sixte Thierry, Florian Cabillic et al. · Human Pathology · 2016 · 120 citations

Veterinary Medicine, Oncology, Pathology +13

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures

Sandrine Eimer, Frédéric Dugay, Kelly Airiau et al. · Neuro-Oncology · 2012 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinicopathological characteristics of <i>ROS1-</i> and <i>RET-</i>rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations

Frédéric Dugay, Francisco Llamas‐Gutierrez, Marjory Gournay et al. · Oncotarget · 2017 · 45 citations · Full text

Life Sciences, Oncology, Pathology +12

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype

Solène‐Florence Kammerer‐Jacquet, Angélique Brunot, A. Pladys et al. · Clinical Genitourinary Cancer · 2016 · 34 citations

Medicine, Oncology, Pathology +14